Osteopore is going nowhere soon:revenues fell from S$900k to...

  1. 369 Posts.
    lightbulb Created with Sketch. 112
    Osteopore is going nowhere soon:
    • revenues fell from S$900k to A400k from 2018 to 2019 - a massive red flag
    • it only has FDA approval for cranioplasty, and not for any other use case - massively limits it's so called addressable market
    Fair value of Osteopore is likely $0.10

    DYOR
    Last edited by BillWackman: 13/09/20
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.2¢
Change
0.001(9.09%)
Mkt cap ! $2.278M
Open High Low Value Volume
1.1¢ 1.3¢ 1.1¢ $85.40K 7.123M

Buyers (Bids)

No. Vol. Price($)
14 3999677 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 146638 4
View Market Depth
Last trade - 14.46pm 31/07/2025 (20 minute delay) ?
OSX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.